Key USDOJ, SEC, FBI and Fortune 500 Decision-Makers to Attend ACI’s 17th New York FCPA Conference

NEW YORK - March 26, 2015 - PRLog -- Widely regarded as one of the premier networking and compliance benchmarking opportunities, American Conference Institute’s 17^th Annual New York Conference on the Foreign Corrupt Practices Act is scheduled for May 19-20, 2015.  Participants will benefit from a worthwhile opportunity to interface with a new 2015 line-up of decision-makers from government and industry, including:

- Andrew Weissmann, Chief, Criminal Division, Fraud Section, US Department of Justice

- Charles E. Cain, Deputy Chief, FCPA Unit, US Securities and Exchange Commission

- Robert Anderson, Jr. (Executive Assistant Director, Criminal, Cyber, Response, and Services Branch, FBI

- Christine E. Neal, Senior Investigations Counsel, Division of Enforcement - FCPA Unit, U.S. Securities and Exchange Commission

- Keith Carr, Group General Counsel, Alstom

- Terence Gilroy, Vice President, Legal – Financial Crime, Barclays

- Eduardo Crosa, Vice President, Global Anti-Corruption, Credit Suisse

- Linda Davidoff, Vice President, Global Compliance, Viacom

- Alex Mendoza, Corporate Counsel, Alcatel-Lucent

- Joseph M. Azam, SVP & Associate General Counsel, Anti-Bribery, HSBC

- Katia F. Grow, Senior Managing Counsel, Compliance and Global Anti-Bribery Counsel, The Coca-Cola Company

- Joshua Drew, VP and Associate General Counsel, Ethics and Anti-Corruption, HP

- Amy Schuh, Executive Director, Global Investigations, Merck & Co

- Ana Iacovetta, Associate General Counsel, Trust & Compliance Officer, IBM

- Matthew Heiman, Vice President, Chief Compliance & Ethics Officer, Tyco

- Jonathan Drimmer, Vice President, Deputy General Counsel, Barrick Gold

Unlike other events, the content is highly sophisticated, with panels focusing on the most pressing compliance and enforcement issues confronting industry.  The conference will also facilitate enhanced benchmarking through anonymous audience polling, whereby participants can compare responses to questions on highly complex global challenges.  New panels include:

♦ FCPA Disclosures and the Impact on Credit, Mitigation and Settlement Prospects: Strategic Insights on Balancing Company, Board, Management, Lawyer and Accountant Objectives

♦ Conducting Effective FCPA Compliance Testing and Reviews

♦ “Agency” Under the FCPA: Assessing and Mitigating Risks Posed by Subsidiaries, Affiliates and JVs

♦ SEC Oversight and Internal Controls: Implementing Effective Internal Controls and Overcoming Common Industry Compliance Weaknesses

♦ Balancing FCPA Compliance with European and Asian Data Privacy Restrictions

For more information and to register, please call 888-224-2480 or register online by visiting http://www.fcpaconference.com/Pharma/